Cargando…

Metabolic Syndrome in Patients Undergoing Coronary Angiography

INTRODUCTION: Metabolic Syndrome (MetS) is basically a cluster of cardiovascular risks that involve changes in metabolic and hemodynamic indicators; various organizations have defined it with small differences. Metabolic syndrome is a lethal endocrinopathy starting with insulin resistance and inviti...

Descripción completa

Detalles Bibliográficos
Autores principales: Atik, Derya, Atik, Cem, Karatepe, Hilal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AVICENA, d.o.o., Sarajevo 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315642/
https://www.ncbi.nlm.nih.gov/pubmed/25684840
http://dx.doi.org/10.5455/aim.2014.22.360-364
_version_ 1782355510923624448
author Atik, Derya
Atik, Cem
Karatepe, Hilal
author_facet Atik, Derya
Atik, Cem
Karatepe, Hilal
author_sort Atik, Derya
collection PubMed
description INTRODUCTION: Metabolic Syndrome (MetS) is basically a cluster of cardiovascular risks that involve changes in metabolic and hemodynamic indicators; various organizations have defined it with small differences. Metabolic syndrome is a lethal endocrinopathy starting with insulin resistance and inviting a chain of systemic disorders such as abdominal obesity, glucose intolerance or diabetes mellitus (DM), dyslipidemia, hypertension (HT) and coronary artery disease (CAD). MATERIAL AND METHODS: This prospective and descriptive study was conducted at the Cardiology Clinic of a Private Hospital in Osmaniye between January 2014 and May 2014. The study population included all patients who were administered a CA procedure at the Cardiology Clinic of Private New Life Hospital in Osmaniye in 2014. RESULTS: The majority of the patients were male (63.3%), the mean age was 59.09±10.98, vast majority of them had social security (98.5%), 32.8% of them smoked, 7.2% had peripheral arterial disease (PAD), 52.5% were diagnosed with DM, 24.8% with HT, percutaneous transluminal coronary angioplasty (PTCA) or stent was administered to 40.3% of the patients who underwent CA and coronary artery bypass grafting (CABG) was decided for 15.5% of them. 41.8% of the patients met the MetS diagnosis criteria. The mean BMI was found to be 28.61±4.68, the mean FBS to be 143.20±74.83, the mean triglyceride value to be 168.73±96.94 and the mean HDL value to be 37.04±9.20. Although male gender came first among the patients who underwent CA, the prevalence of MetS did not show a statistically significant correlation with gender, mean age or smoking. The prevalence of HT, PAD and DM was significantly higher in the patients who met the MetS criteria. The mean values of FBS, HDL, CK-MB, triglyceride and cholesterol were also significantly higher in the patients who met the MetS criteria. As BMI increased, the rate at which MetS criteria are met also increased. CONCLUSION: The objective is to prevent diabetes and cardiovascular diseases. Weight loss achieved with proper nutrition and an exercise program will have a reversing effect on all the disorders seen in metabolic syndrome.
format Online
Article
Text
id pubmed-4315642
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher AVICENA, d.o.o., Sarajevo
record_format MEDLINE/PubMed
spelling pubmed-43156422015-02-13 Metabolic Syndrome in Patients Undergoing Coronary Angiography Atik, Derya Atik, Cem Karatepe, Hilal Acta Inform Med Original Paper INTRODUCTION: Metabolic Syndrome (MetS) is basically a cluster of cardiovascular risks that involve changes in metabolic and hemodynamic indicators; various organizations have defined it with small differences. Metabolic syndrome is a lethal endocrinopathy starting with insulin resistance and inviting a chain of systemic disorders such as abdominal obesity, glucose intolerance or diabetes mellitus (DM), dyslipidemia, hypertension (HT) and coronary artery disease (CAD). MATERIAL AND METHODS: This prospective and descriptive study was conducted at the Cardiology Clinic of a Private Hospital in Osmaniye between January 2014 and May 2014. The study population included all patients who were administered a CA procedure at the Cardiology Clinic of Private New Life Hospital in Osmaniye in 2014. RESULTS: The majority of the patients were male (63.3%), the mean age was 59.09±10.98, vast majority of them had social security (98.5%), 32.8% of them smoked, 7.2% had peripheral arterial disease (PAD), 52.5% were diagnosed with DM, 24.8% with HT, percutaneous transluminal coronary angioplasty (PTCA) or stent was administered to 40.3% of the patients who underwent CA and coronary artery bypass grafting (CABG) was decided for 15.5% of them. 41.8% of the patients met the MetS diagnosis criteria. The mean BMI was found to be 28.61±4.68, the mean FBS to be 143.20±74.83, the mean triglyceride value to be 168.73±96.94 and the mean HDL value to be 37.04±9.20. Although male gender came first among the patients who underwent CA, the prevalence of MetS did not show a statistically significant correlation with gender, mean age or smoking. The prevalence of HT, PAD and DM was significantly higher in the patients who met the MetS criteria. The mean values of FBS, HDL, CK-MB, triglyceride and cholesterol were also significantly higher in the patients who met the MetS criteria. As BMI increased, the rate at which MetS criteria are met also increased. CONCLUSION: The objective is to prevent diabetes and cardiovascular diseases. Weight loss achieved with proper nutrition and an exercise program will have a reversing effect on all the disorders seen in metabolic syndrome. AVICENA, d.o.o., Sarajevo 2014-12 2014-12-19 /pmc/articles/PMC4315642/ /pubmed/25684840 http://dx.doi.org/10.5455/aim.2014.22.360-364 Text en Copyright: © AVICENA http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Paper
Atik, Derya
Atik, Cem
Karatepe, Hilal
Metabolic Syndrome in Patients Undergoing Coronary Angiography
title Metabolic Syndrome in Patients Undergoing Coronary Angiography
title_full Metabolic Syndrome in Patients Undergoing Coronary Angiography
title_fullStr Metabolic Syndrome in Patients Undergoing Coronary Angiography
title_full_unstemmed Metabolic Syndrome in Patients Undergoing Coronary Angiography
title_short Metabolic Syndrome in Patients Undergoing Coronary Angiography
title_sort metabolic syndrome in patients undergoing coronary angiography
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315642/
https://www.ncbi.nlm.nih.gov/pubmed/25684840
http://dx.doi.org/10.5455/aim.2014.22.360-364
work_keys_str_mv AT atikderya metabolicsyndromeinpatientsundergoingcoronaryangiography
AT atikcem metabolicsyndromeinpatientsundergoingcoronaryangiography
AT karatepehilal metabolicsyndromeinpatientsundergoingcoronaryangiography